Ionis Pharmaceuticals, Inc. (IONS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Ionis Pharmaceuticals, Inc. (IONS)
Go deeper and ask any question about IONS
Company Performance
Current Price
as of Sep 13, 2024$42.19
P/E Ratio
N/A
Market Cap
$6.65B
Description
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Metrics
Overview
- HQCarlsbad, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerIONS
- Price$42.19+2.85%
Trading Information
- Market Cap$6.65B
- Float91.69%
- Average Daily Volume (1m)1,965,238
- Average Daily Volume (3m)1,587,972
- EPS-$2.53
Company
- Revenue$813.95M
- Rev Growth (1yr)19.55%
- Net Income-$66.27M
- Gross Margin95.67%
- EBITDA Margin-26.86%
- EBITDA-$60.51M
- EV$6.85B
- EV/Revenue8.42
- P/EN/A
- P/S7.57
Documents
SEC Filings
Earnings Calls
Factset Street Account